MORGAN STANLEY

Holdings History for Syndax Pharmaceuticals Inc - Common Stock (SNDX)

Symbol: SNDX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 5.36M shares
Security Ownership: 6.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Syndax Pharmaceuticals Inc Common Stock (SNDX)

2025-02-05 - Morgan Stanley has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.36M shares of Syndax Pharmaceuticals Inc Common Stock (SNDX). This represents 6.3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	6.3%		$65.9M	5.36M			$12.29	13G	12/31/2024	5 Feb 2025 10:03:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0%	+0%	$70.2M	5.31M	+4,425,677	+499%	$13.22	Q4 2024
9/30/2024	0%	+0%	$17.1M	887K	+130,913	+17.3%	$19.25	Q3 2024
6/30/2024	0%	0%	$15.5M	756K	-1,059,526	-58.4%	$20.53	Q2 2024
3/31/2024	0%		$43.2M	1.82M			$23.80	Q1 2024
12/31/2023	0%		$36M	1.66M			$21.61	Q4 2023
9/30/2023	0%	+0%	$7.99M	550K	+120,309	+28%	$14.52	Q3 2023
6/30/2023	0%	0%	$8.99M	430K	-664,124	-60.7%	$20.93	Q2 2023
3/31/2023	0%	+0%	$23.1M	1.09M	+944,475	+632%	$21.12	Q1 2023
12/31/2022	0%	0%	$3.8M	149K	-9,183	-5.79%	$25.45	Q4 2022
9/30/2022	0%	0%	$3.81M	159K	-133,112	-45.6%	$24.03^*	Q3 2022
6/30/2022	0%	0%	$5.61M	292K	-406,024	-58.2%	$19.24	Q2 2022
3/31/2022	0%	+0%	$12.1M	698K	+420,212	+151%	$17.38	Q1 2022
12/31/2021	0%	+0%	$6.07M	277K	+24,337	+9.61%	$21.89	Q4 2021
9/30/2021	0%	+0%	$4.84M	253K	+204,243	+418%	$19.11	Q3 2021
6/30/2021	0%	0%	$839K	48.9K	-351	-0.71%	$17.16	Q2 2021
3/31/2021	0%	0%	$1.1M	49.2K	-11,988	-19.6%	$22.36	Q1 2021
12/31/2020	0%	+0%	$1.36M	61.2K	+18,362	+42.8%	$22.24	Q4 2020
9/30/2020	0%	0%	$633K	42.9K	-107,192	-71.4%	$14.76	Q3 2020
6/30/2020	0%	+0%	$2.22M	150K	+79,301	+112%	$14.81	Q2 2020
3/31/2020	0%	0%	$776K	70.8K	-24,977	-26.1%	$10.97	Q1 2020
12/31/2019	0%	+0%	$841K	95.7K	+4,363	+4.77%	$8.78	Q4 2019
9/30/2019	0%	+0%	$683K	91.4K	+30,680	+50.5%	$7.47	Q3 2019
6/30/2019	0%	0%	$566K	60.7K	-7,381	-10.8%	$9.32^*	Q2 2019
3/31/2019	0%	0%	$357K	68.1K	-83,417	-55.1%	$5.24	Q1 2019
12/31/2018	0%	0%	$675K	151K	-118,099	-43.8%	$4.46	Q4 2018
9/30/2018	0%	+0%	$2.18M	270K	+26,043	+10.7%	$8.08	Q3 2018
6/30/2018	0%	+0%	$1.71M	244K	+3,286	+1.37%	$7.02	Q2 2018
3/31/2018	0%	0%	$3.42M	240K	-25,335	-9.54%	$14.23	Q1 2018
12/31/2017	0%	+0%	$2.33M	266K	+17,687	+7.13%	$8.76	Q4 2017
9/30/2017	0%	+0%	$2.9M	248K	+122,699	+98%	$11.70	Q3 2017
6/30/2017	0%	+0%	$1.75M	125K	+5,228	+4.36%	$13.97	Q2 2017
3/31/2017	0%	+0%	$1.65M	120K	+81,159	+209%	$13.72	Q1 2017
12/31/2016	0%	+0%	$278K	38.8K	+20,891	+116%	$7.16	Q4 2016
9/30/2016	0%	+0%	$272K	17.9K	+15,819	+747%	$15.16	Q3 2016
6/30/2016	0%	0%	$20K	2.12K	-1,361	-39.1%	$9.44	Q2 2016
3/31/2016	0%	+0%	$46K	3.48K	+3,479	NEW	$13.22^*	Q1 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.